These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3518863)
1. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum. Wilson RL; Kamata K; Bigelow JC; Rebec GV; Wightman RM Brain Res; 1986 Apr; 370(2):393-6. PubMed ID: 3518863 [TBL] [Abstract][Full Text] [Related]
2. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-cortico-neostriatal loop. Pierce RC; Clemens AJ; Grabner CP; Rebec GV J Neurochem; 1994 Oct; 63(4):1499-507. PubMed ID: 7931303 [TBL] [Abstract][Full Text] [Related]
3. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats. Pierce RC; Rebec GV Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478 [TBL] [Abstract][Full Text] [Related]
4. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats. Yount SE; Kraft ME; Pierce RC; Langley PE; Rebec GV Life Sci; 1991; 49(17):1237-44. PubMed ID: 1943438 [TBL] [Abstract][Full Text] [Related]
5. Unilateral, intranigral infusions of amphetamine produce differential, bilateral changes in unit activity and extracellular levels of ascorbate in the neostriatum of the rat. Wilson RL; Kamata K; Wightman RM; Rebec GV Brain Res; 1986 Oct; 384(2):342-7. PubMed ID: 3779385 [TBL] [Abstract][Full Text] [Related]
6. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum. Oh C; Gardiner TW; Rebec GV Brain Res; 1989 Feb; 480(1-2):184-9. PubMed ID: 2565749 [TBL] [Abstract][Full Text] [Related]
7. Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat. Kamata K; Wilson RL; Alloway KD; Rebec GV Brain Res; 1986 Jan; 362(2):331-8. PubMed ID: 3942882 [TBL] [Abstract][Full Text] [Related]
8. Behavioral and subthalamic effects of combining a fetal ventral mesencephalic transplant in striatum with an electrolytic lesion of the entopeduncular nucleus in the rat with a unilateral 6-OHDA lesion of substantia nigra. Olds ME; Jacques DB; Kopyov O Synapse; 2003 May; 48(2):90-9. PubMed ID: 12619043 [TBL] [Abstract][Full Text] [Related]
9. Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine. White LK; Maurer M; Kraft ME; Oh C; Rebec GV Pharmacol Biochem Behav; 1990 Jul; 36(3):485-9. PubMed ID: 2377651 [TBL] [Abstract][Full Text] [Related]
10. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum. Basse-Tomusk A; Rebec GV Pharmacol Biochem Behav; 1990 Jan; 35(1):55-60. PubMed ID: 2315370 [TBL] [Abstract][Full Text] [Related]
11. Effect of direct and indirect dopamine agonists on brain extracellular ascorbate levels in the striatum and nucleus accumbens of awake rats. Phebus LA; Roush ME; Clemens JA Life Sci; 1990; 47(15):1317-23. PubMed ID: 1978214 [TBL] [Abstract][Full Text] [Related]
12. Interference by DOPAC and ascorbate during attempts to measure drug-induced changes in neostriatal dopamine with Nafion-coated, carbon-fiber electrodes. Wiedemann DJ; Basse-Tomusk A; Wilson RL; Rebec GV; Wightman RM J Neurosci Methods; 1990 Oct; 35(1):9-18. PubMed ID: 2148961 [TBL] [Abstract][Full Text] [Related]
13. Behavioral activation in rats requires endogenous ascorbate release in striatum. Rebec GV; Wang Z J Neurosci; 2001 Jan; 21(2):668-75. PubMed ID: 11160445 [TBL] [Abstract][Full Text] [Related]
14. Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat. Wilson RL; Wightman RM Brain Res; 1985 Jul; 339(2):219-26. PubMed ID: 4027622 [TBL] [Abstract][Full Text] [Related]
15. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. Yamamoto BK; Nash JF; Gudelsky GA J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076 [TBL] [Abstract][Full Text] [Related]
16. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143 [TBL] [Abstract][Full Text] [Related]
17. In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate. Ewing AG; Wightman RM; Dayton MA Brain Res; 1982 Oct; 249(2):361-70. PubMed ID: 6814706 [TBL] [Abstract][Full Text] [Related]
18. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry. Hefti F; Melamed E Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Zetterström T; Herrera-Marschitz M; Ungerstedt U Brain Res; 1986 Jun; 376(1):1-7. PubMed ID: 3087581 [TBL] [Abstract][Full Text] [Related]